Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v4-FR
Language French French
Date Updated 2020-08-27 2020-08-27
Drug Identification Number 02439654 02439654
Brand name TEVA-BUPROPION XL TEVA-BUPROPION XL
Common or Proper name BUPROPION XL 150MG SR TAB BUPROPION XL 150MG SR TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients BUPROPION HYDROCHLORIDE BUPROPION HYDROCHLORIDE
Strength(s) 150MG 150MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 90's & 500's 90's & 500's
ATC code N06AX N06AX
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-07-08 2020-07-08
Estimated end date 2020-08-31 2020-08-31
Actual end date 2020-08-26 2020-08-26
Shortage status Resolved Resolved
Company comments
Health Canada comments